EGFR and glioblastoma: Collectively, these results validate the use of ColabFold for accurate modeling of MHC class I peptide complexes and highlight the EGFR p.Ala289Asp-derived epitope as a promising candidate for HLA-A*68:01-restricted immune targeting in glioblastoma.